ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 197

Synergy Between Hematopoietic and Radioresistant Stromal Cells Is Required for Autoimmune Manifestations of Dnase II Deficient Mice

Rebecca Baum1, Kerstin Nundel1, Sudesh Pawaria1,2, Shruti Sharma1, Patricia Busto1, Tara Robidoux1, Katherine A. Fitzgerald1, Ellen M. Gravallese3 and Ann Marshak-Rothstein1, 1Medicine, University of Massachusetts Medical School, Worcester, MA, 2Department of Medicine, University of Massachusetts Medical School, Worcester, MA, 3Lazare Research Bldg Ste 223, University of Massachusetts Medical School, Worcester, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: ANA, Inflammation, innate immunity and rheumatoid arthritis (RA), SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Innate Immunity and Rheumatic Disease Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Toll-like receptors (TLRs) dependent on Unc93b1 and cytosolic sensors dependent on STING detect microbial and endogenous nucleic acids to initiate inflammatory responses that resolve infection, but also contribute to autoimmune diseases. In the DNase II-/- IFNaR-/- (double knock out, DKO) mouse model, DNA accrual results in STING-dependent inflammatory arthritis as well as Unc93b1-dependent autoimmune manifestations, including ANA production, extramedullary hematopoiesis, and splenomegaly. While the role of hematopoietic cells in driving autoimmunity is well established, the contribution of stromal elements to disease pathogenesis is just beginning to be appreciated. Here we utilized bone marrow chimeras to determine the contribution of hematopoietic vs. radioresistant host cells to autoimmune manifestations in DKO mice.

Methods: Lethally irradiated Het (DNase II+/- IFNaR-/-) or DKO mice were reconstituted with Het or DKO stem cells to generate four experimental groups: Het (donor)→Het (recipient), DKO→DKO, Het→DKO and DKO→Het. Additionally, Unc93b1-/- DNase II-/- IFNaR-/-triple KO (Unc93b1 TKO) mice were used to generate DKO→Unc93b1 TKO and Unc93b1 TKO→DKO chimeras. Complete hematopoietic repopulation by donor BM cells in all groups was verified by flow cytometry using appropriate markers. Inflammation was assessed by clinical scoring (scale of 1-12), histologic scoring in ankle joints (scale of 1-4), and by measuring matrix metalloproteinase 3 (MMP-3) protein levels in the sera. Splenomegaly, ANA production, and extramedullary hematopoiesis were evaluated as other indicators of disease.

Results: As expected, Het→Het chimeras showed no evidence of arthritis while DKO→DKO mice showed significant inflammation in distal joints. Remarkably, neither the DKO→Het nor Het→DKO mice developed any clinical or histologic signs of arthritis over a 10-month period. Serum MMP3, a surrogate marker for inflammation, reflected the arthritis scores and further confirmed absence of inflammation in the DKO→Het and Het→DKO chimeras. The massive splenomegaly and extramedullary hematopoiesis observed in DKO mice were absent in the Het→Het chimeras and present in DKO→DKO mice. Surprisingly however, the Het→DKO and DKO→Het mice failed to develop splenomegaly or extramedullary hematopoiesis. Furthermore, autoimmune manifestations dependent on Unc93b1 were present in the DKO→Unc93b1 TKO mice but absent in Unc93b1 TKO→DKO chimeras.

Conclusion: These data reveal that both hematopoietic and radioresistant host cells must be DNase II-deficient in order for STING-dependent inflammatory arthritis to develop. Additional features of autoimmunity in these mice known to depend on Unc93b1, and therefore on endosomal TLRs, also require DNase II deficiency in both donor and host compartments, but require functional TLRs only in hematopoietic cells. These findings point to a critical interplay between endosomal and cytosolic nucleic acid receptors in the development of systemic autoimmunity, and suggest that targeting both hematopoietic and non-hematopoietic cells may be advantageous in autoimmune settings.


Disclosure: R. Baum, None; K. Nundel, None; S. Pawaria, None; S. Sharma, None; P. Busto, None; T. Robidoux, None; K. A. Fitzgerald, None; E. M. Gravallese, None; A. Marshak-Rothstein, None.

To cite this abstract in AMA style:

Baum R, Nundel K, Pawaria S, Sharma S, Busto P, Robidoux T, Fitzgerald KA, Gravallese EM, Marshak-Rothstein A. Synergy Between Hematopoietic and Radioresistant Stromal Cells Is Required for Autoimmune Manifestations of Dnase II Deficient Mice [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/synergy-between-hematopoietic-and-radioresistant-stromal-cells-is-required-for-autoimmune-manifestations-of-dnase-ii-deficient-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synergy-between-hematopoietic-and-radioresistant-stromal-cells-is-required-for-autoimmune-manifestations-of-dnase-ii-deficient-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology